Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: "Strategic Partnership"? pautaotzu
2
Jan 23, 2008 06:53AM

Re: "Strategic Partnership"? pautaotzu

posted on Jan 23, 2008 01:11PM

This was your suggestion re the Forbes article:

 

TPL through Alliacense could manage the joint venture IP portfolio for all the companies mentioned in the following article.

and they could actually combine Intellasys' IP also.

I would call this a business resolution.

 

You then suggested that TPL offer $2.00 per PTSC share(a fair price):

 

TPL could offer the retail shareholder  500% times the current pps.

5 x .40 = $2/sh

I don't think any court in Delaware would see a problem with that offer

 

You now say:

 

I have never said it anything would be fair to PTSC.  That is why we have to be vigilant

 

 

Please, what is it that you are trying to say?

 

 

 

Be well

 

Share
New Message
Please login to post a reply